Business & Finance
Activist Investor Ananym Urges Bio-Techne to Consider Selling
Key Points
Health Activist Investor Ananym Urges Bio-Techne to Consider Selling Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale. Ananym said in a letter dated Monday to Bio-Techne’s board that the company has underperformed its peers in life-science tools as well as the broader market. A sale to a larger industry player would give more value to Bio-Techne than it can create as a...
Health
Activist Investor Ananym Urges Bio-Techne to Consider Selling
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.
Ananym said in a letter dated Monday to Bio-Techne’s board that the company has underperformed its peers in life-science tools as well as the broader market. A sale to a larger industry player would give more value to Bio-Techne than it can create as a standalone entity, according to the letter, which was reviewed by Bloomberg News.